Pasquale Rescigno

Genomic correlates of clinical outcome in advanced prostate cancer

Wassim Abida, Joanna Cyrta, Glenn Heller et al. · Proceedings of the National Academy of Sciences · 2019 · 1.3K citations · Full text

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial

Joaquı́n Mateo, Núria Porta, Diletta Bianchini et al. · The Lancet Oncology · 2019 · 632 citations · Full text

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer

Alec Paschalis, Beshara Sheehan, Ruth Riisnaes et al. · European Urology · 2019 · 452 citations · Full text

Plasma <i>AR</i> and abiraterone-resistant prostate cancer

Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca et al. · Science Translational Medicine · 2015 · 431 citations · Full text

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition

Jane Goodall, Joaquı́n Mateo, Wei Yuan et al. · Cancer Discovery · 2017 · 410 citations · Full text